Demonstrates how metabolic enzymes regulate gene expression via histone lactylation, suggesting a novel therapeutic avenue for tumors.
Histone lactylation is critically involved in the regulation of gene expression and the modulation of diverse cellular processes in both normal and tumor cells. A recent study by Zhu et al. [Cell Metab. 37, 361–376] demonstrated that ACSS2 functions as a bona fide lactyl-CoA synthetase, converting lactate into lactyl-CoA. In response to elevated aerobic glycolysis and EGFR activation, ERK-mediated phosphorylation drives the nuclear translocation of ACSS2, promoting the formation of the ACSS2–KAT2A complex. KAT2A utilizes ACSS2-derived lactyl-CoA and acts as a lactyltransferase to promote histone lactylation, gene expression, tumor growth, and immune evasion.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: